SPECIFIC SERUM IMMUNOGLOBULIN G TO CHLAMYDIA PNEUMONIAE IN HEALTHY CHILDREN AND ADULTS (SOUTH-EAST OF IRAN)
AbstractBackground: Chlamydia pneumoniae (C. pneumonia) is an obligate intracellular bacterium and recognized as a risk factor for several diseases such as asthma, atherosclerosis and arthritis. The aim of this study was to determine the sero-prevalence of C. pneumonia in healthy subjects in different age groups. Methods: The serum levels of anti C. pneumonia IgG were measured by using of ELISA. Results: Totally, 630 subjects (164 children and 466 adults) were included into study. The sero-prevalence and the mean titer of anti C. pneumonia antibody were 11.3% and 14.48±2.18 RU/mL; at age ≤10 years, 15% and 17.47±2.40 RU/mL at age 11–20 years, 21% and 25.15±4.56 RU/mL at age 21–30 years group, 40% and 53.77±6.40 RU/mL at age 31–40 years, 94% and 146.41±8.95 RU/mL at age 41–50 years, 98% and 153.59±10.38 RU/mL at age 51–60 years, 96% and 138.80±12.78 RU/mL at age 61–70 years, respectively. The differences of the sero-prevalence and the mean titer of anti C. pneumonia antibody between age groups were significant (p<0.0001). The sero-prevalence and the mean titer of anti C. pneumonia antibody were 11.6% and 14.33 ± 1.49 RU/mL in children and 65.5% and 97.40±4.46 RU/mL in adults. The sero-prevalence and the mean titer of anti C. pneumonia antibody were significantly higher in adults in comparison with those in children (p<0.0001). Conclusion: These findings showed that the sero-prevalence and titer of anti C. pneumonia IgG were increased with advanced ages and were higher in adults as compared to children. Keywords: Chlamydia pneumonia; IgG; Sero-prevalence; Age; Adults; Children; Iran
Villegas E, Sorlozano A, Gutierrez J. Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives. J Med Microbiol 2010;59 (11):1267–74.
Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer 2011;47(5):742–7.
Tang LF, Wang DF, Cao LQ, Wu XD, Lu J, Yu FF. [Correlation between Chlamydia pneumoniae infection and chronic obstructive pulmonary disease]. Zhonghua Liu Xing Bing Xue Za Zhi 2012;33(10):1072–4.
Awasthi S, Yadav KK, Agarwal J. Chlamydia pneumoniae infection associated with uncontrolled asthma: a hospital based cross sectional study. Indian J Pediatr 2012; 79(10):1318–22.
Lu Q, Xu J, Liu H. Association between Chlamydia pneumoniae IgG antibodies and migraine. J Headache Pain 2009;10(2):121–4.
Shima K, Kuhlenbaumer G, Rupp J. Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? Med Microbiol Immunol 2010;199(4):283–9.
Di Pietro M, Schiavoni G, Sessa V, Pallotta F, Costanzo G, Sessa R. Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor? Osteoporos Int 2013;24(5):1677–82.
Roulis E, Polkinghorne A, Timms P. Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol 2013;21(3):120–8.
Jafarzadeh A, Esmaeeli-Nadimi A, Shariati M. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease. Iran J Immunol 2008;5(1):51–6.
Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 2007;44(4):568–76.
Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med 2005;26(6):617–24.
Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol 1991;29(4):816–8.
Aldous MB, Grayston JT, Wang SP, Foy HM. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis 1992;166(3):646–9.
Al-Younes HM. High prevalence of Chlamydia pneumoniae infection in an asymptomatic Jordanian population. J Microbiol Immunol Infect 2014;47(5):412–7.
Cui J, Yan W, Ni A, Kong L, Chen L. [Detection of serum Chlamydia pneumoniae antibodies and analysis of epidemiologic data in 5 years]. Zhonghua Yi Xue Za Zhi 2014;94(12):919–23.
Koh WP, Taylor MB, Hughes K, Chew SK, Fong CW, Phoon MC, et al. Sero-prevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore. Int J Epidemiol. 2002;31(5):1001–7
Lin TM, Kuo CC, Chen WJ, Lin FJ, Eng HL. Sero-prevalence of Chlamydia pneumoniae infection in Taiwan. J Infect 2004;48(1):91–5.
Paldanius M, Bloigu A, Alho M, Leinonen M, Saikku P. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol 2005;12(5):654–9.
Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol 1998;36(11):342–8.
Sidal M, Kilic A, Unuvar E, Oguz F, Onel M, Agacfidan A, et al. Frequency of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in children. J Trop Pediatr 2007;53(4):225–31.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.